1. Home
  2. PSNYW vs CERS Comparison

PSNYW vs CERS Comparison

Compare PSNYW & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

PSNYW

Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

HOLD

Current Price

$2.68

Market Cap

290.9M

ML Signal

HOLD

Logo Cerus Corporation

CERS

Cerus Corporation

HOLD

Current Price

$2.55

Market Cap

276.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSNYW
CERS
Founded
2017
1991
Country
Sweden
United States
Employees
1686
N/A
Industry
Auto Manufacturing
EDP Services
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
290.9M
276.0M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PSNYW
CERS
Price
$2.68
$2.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.5K
2.4M
Earning Date
03-06-2025
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
27.27
EPS
N/A
N/A
Revenue
$2,034,261,000.00
$51,326,000.00
Revenue This Year
N/A
$19.95
Revenue Next Year
$79.49
$8.84
P/E Ratio
N/A
N/A
Revenue Growth
N/A
30.68
52 Week Low
$0.14
$1.15
52 Week High
$7.50
$3.15

Technical Indicators

Market Signals
Indicator
PSNYW
CERS
Relative Strength Index (RSI) 42.09 48.93
Support Level $2.45 $1.94
Resistance Level $3.50 $2.68
Average True Range (ATR) 0.23 0.16
MACD 0.01 -0.03
Stochastic Oscillator 23.68 34.88

Price Performance

Historical Comparison
PSNYW
CERS

About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)

Polestar Automotive Holding UK PLC is a pure play, premium electric car brand, designing performance cars engineered to excite consumers and drive change. It believes that it defines market standards in design, innovation and sustainability. It is determined to improve society by accelerating the shift to sustainable mobility. The company conducts its business as one operating segment with primary commercial operations in Europe, North America, Asia Pacific and various importer markets. The company generates majority of revenue from United Kingdom.

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Share on Social Networks: